Blood cultures were processed in the BD BACTEC 9240 system (Becton Dickinson, USA). Bacterial species were identified by the morphology and color in the chromogenic agar, and confirmed by BD GNB ID or BD E/NF crystal kit (Becton Dickinson, USA). Antibiotic susceptibility was determined by the disk diffusion method, in accordance with the procedures of the Clinical and Laboratory Standards Institute (CLSI), and was interpreted according to the zone criteria of CLSI issued in 2018 (M100-S21).17 The drugs tested included ampicillin, ampicillin/sulbactam, gentamicin, amikacin, cefazolin, cefuroxime, ceftriaxone, ceftazidime, cefepime, ciprofloxacin, ertapenem, and imipenem or meropenem. Susceptibility to 3GCs was defined as the clear zone diameter of ceftriaxone ≥23 mm, cefotaxime ≥26 mm, or ceftazidime ≥21 mm,17 and susceptibility to fluoroquinolones as the clear zone diameter of levofloxacin ≥17 mm or ciprofloxacin ≥21 mm.17
E nf crystal kit
Manufactured by BD
Sourced in United States
The BD E/NF crystal kit is a laboratory equipment product designed for the detection and identification of crystals. It provides the necessary tools and reagents to assist in the analysis and characterization of various crystal formations.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using e nf crystal kit
1
Blood Culture Identification and Antibiotic Susceptibility
2
Antibiotic Susceptibility Testing Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Blood cultures were processed in the BD BACTEC 9240 system (Becton Dickinson, USA). Bacterial species were identi ed by the morphology and color in the chromogenic agar, and con rmed by BD GNB ID or BD E/NF crystal kit (Becton Dickinson, USA). Antibiotic susceptibility was determined by the disk diffusion method, in accordance with the procedures of the Clinical and Laboratory Standards Institute (CLSI), and was interpreted according to the zone criteria of CLSI issued in 2018 (M100-S21) [17] . The drugs tested included ampicillin, ampicillin/sulbactam, gentamicin, amikacin, cefazolin, cefuroxime, ceftriaxone, ceftazidime, cefepime, cipro oxacin, ertapenem, and imipenem or meropenem. Susceptibility to 3GCs was de ned as the clear zone diameter of ceftriaxone > 23 mm, cefotaxime > 26 mm, or ceftazidime > 21 mm [17] , and susceptibility to uoroquinolones as the clear zone diameter of levo oxacin > 17 mm or cipro oxacin > 21 mm [17] .
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!